Opportunity Information: Apply for CDC RFA GH11 1169
Apply for CDC RFA GH11 1169
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Formative Assessment of HIV Risk and Size Estimation Among Most At Risk Populations (MARPs) and Integrated Biological and Behavioral Surveillance Among MARPs in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 17, 2011 and posted on Mar 1, 2011.
- Applicants must submit their applications by Apr 28, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $20,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,103,500.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: For profit organizations other than small businesses City or township governments Private institutions of higher education Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments Native American tribal governments (Federally recognized) Small businesses.
- Eligible applicants that can apply for this funding opportunity are Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Non domestic (non U.S.) entity Other (specify) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA GH11-1169) is a CDC cooperative agreement under PEPFAR focused on strengthening HIV-related public health surveillance in the Republic of Zambia among "Most At Risk Populations" (MARPs). The main intent is to support formative assessment work on HIV risk and population size estimation, along with integrated biological and behavioral surveillance (often referred to as IBBS) for key populations most affected by HIV transmission. The target MARPs are explicitly described as commercial sex workers (CSWs) of both sexes, men who have sex with men (MSM), injecting drug users (IDUs), and the sexual partners of these individuals. In practical terms, the program is meant to help generate credible, usable data on how large these populations are, what their risk environments look like, and what their HIV and related health indicators are, so that prevention, testing, treatment linkage, and other services can be better planned and monitored under the PEPFAR framework.
The mechanism is a cooperative agreement, which generally means the CDC expects substantial involvement beyond simply issuing funds, such as technical collaboration on study design, surveillance methods, analysis plans, and dissemination of findings. The activity category is health, and the relevant CFDA number listed is 93.067 (Global AIDS). The opportunity projected up to two awards, with an estimated total funding level of $20,000,000 across the program. The award ceiling is stated as $1,103,500, and the award floor is $0, indicating proposals could vary in size and scope depending on the proposed approach, capacity, and negotiated workplan. There is no cost sharing or matching requirement, which lowers the barrier for applicants that may not have flexible funds available to meet a match.
Eligibility is broad and includes many organization types that could credibly implement surveillance and research activities. Eligible applicants include nonprofits with or without 501(c)(3) status, for-profit organizations other than small businesses, small/micro businesses including small minority- and women-owned businesses, universities and colleges, research institutions, hospitals, community-based and faith-based organizations, and government entities (state and local governments or their bona fide agents). Tribal governments (federally or state recognized) are listed, as are non-U.S. (non-domestic) entities, which is important given the work is to be carried out in Zambia. The notice also explains that a bona fide agent applying on behalf of a state or local government must provide a letter documenting that status, submitted as part of the application package through Grants.gov.
In terms of what the work is aiming to accomplish, the emphasis on "formative assessment" and "size estimation" signals a push to address common gaps in HIV programming for key populations: uncertainty about how many people belong to each population group, where they are located, and what patterns of behavior and service access look like. Integrated biological and behavioral surveillance typically pairs biological testing (for example, HIV and potentially other STI markers depending on the protocol) with structured behavioral data collection (for example, sexual and drug-use risk behaviors, condom use, testing history, exposure to prevention programs, stigma and discrimination, violence, and healthcare utilization). By combining these streams, the program can generate more actionable indicators than either approach alone, such as HIV prevalence alongside behavioral drivers and service coverage measures. The inclusion of sexual partners of MARPs expands the lens beyond the most visible key population members and acknowledges transmission dynamics that extend into broader sexual networks.
Key administrative details include a posted date of March 1, 2011, a creation date of March 17, 2011, and an original/current closing date of April 28, 2011, with an archive date of May 28, 2011. The sponsoring agency is the Centers for Disease Control and Prevention, and applicants needing assistance accessing the full announcement were directed to the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), via the listed phone number (770-488-2700). The announcement also notes that the "Additional Information" link shown is not active and that applicants should use the "Full Announcement" materials associated with the posting for complete requirements, expectations, and submission instructions.
Frequently Asked Questions (FAQs)
What is the name and reference number of this funding opportunity?
This opportunity is identified as CDC RFA GH11-1169. It is described as a CDC cooperative agreement under PEPFAR.
Which agency is sponsoring this opportunity?
The sponsoring agency is the Centers for Disease Control and Prevention (CDC).
What is the overall purpose of this cooperative agreement?
The intent is to strengthen HIV-related public health surveillance in the Republic of Zambia by supporting formative assessment work, HIV risk and population size estimation, and integrated biological and behavioral surveillance (IBBS) among Most At Risk Populations (MARPs) and their sexual partners.
What country is the work focused on?
The activities described are focused on the Republic of Zambia.
What does MARPs mean in this announcement?
MARPs refers to "Most At Risk Populations" most affected by HIV transmission. The announcement explicitly lists commercial sex workers (CSWs) of both sexes, men who have sex with men (MSM), injecting drug users (IDUs), and the sexual partners of these individuals.
Which populations are specifically targeted?
The targeted MARPs are: commercial sex workers (CSWs) of both sexes, men who have sex with men (MSM), injecting drug users (IDUs), and the sexual partners of these individuals.
What kinds of activities does the opportunity emphasize?
The opportunity emphasizes (1) formative assessment related to HIV risk and context, (2) population size estimation for key populations, and (3) integrated biological and behavioral surveillance (IBBS) to produce credible, usable data for HIV program planning and monitoring.
What is "formative assessment" in the context of this opportunity?
In this announcement, formative assessment refers to early, foundational work to better understand HIV risk environments and key population contexts, including where people are located and what patterns of risk and service access look like, to inform surveillance design and program planning.
What is population size estimation and why is it important here?
Population size estimation is work intended to reduce uncertainty about how many people belong to each key population group and, by implication, support more realistic planning, targeting, and monitoring of prevention, testing, treatment linkage, and related services under PEPFAR.
What is IBBS?
IBBS stands for integrated biological and behavioral surveillance. As described, it typically pairs biological testing (for example, HIV and potentially other STI markers depending on the protocol) with structured behavioral data collection (for example, sexual and drug-use behaviors, condom use, testing history, exposure to prevention programs, stigma/discrimination, violence, and healthcare utilization).
What kinds of data are expected to be generated through this work?
The program is intended to generate credible, usable data on: the size of key populations, characteristics of their risk environments, and HIV and related health indicators. By integrating biological and behavioral information, it can also generate indicators that connect HIV prevalence with behavioral drivers and service coverage measures.
How does including the sexual partners of MARPs affect the scope?
The announcement states that including sexual partners expands the lens beyond the most visible members of key populations and acknowledges HIV transmission dynamics that extend into broader sexual networks.
What is the funding mechanism?
The mechanism is a cooperative agreement.
What does "cooperative agreement" mean for the relationship with CDC?
The announcement notes that a cooperative agreement generally means CDC expects substantial involvement beyond issuing funds, such as technical collaboration on study design, surveillance methods, analysis plans, and dissemination of findings.
What is the activity category for this opportunity?
The activity category is health.
What CFDA number is associated with this opportunity?
The CFDA number listed is 93.067 (Global AIDS).
How many awards are expected?
The opportunity projected up to two awards.
What is the estimated total funding level?
The estimated total funding level is $20,000,000 across the program.
What is the award ceiling?
The award ceiling is stated as $1,103,500.
What is the award floor?
The award floor is listed as $0, indicating proposals may vary in size and scope depending on the proposed approach, capacity, and negotiated workplan.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad. Eligible applicants include: nonprofits with or without 501(c)(3) status, for-profit organizations other than small businesses, small/micro businesses (including small minority- and women-owned businesses), universities and colleges, research institutions, hospitals, community-based organizations, faith-based organizations, and government entities (state and local governments or their bona fide agents). Tribal governments (federally or state recognized) are listed, as are non-U.S. (non-domestic) entities.
Are non-U.S. organizations eligible?
Yes. The eligibility list includes non-U.S. (non-domestic) entities, which aligns with the work being carried out in Zambia.
Can a state or local government apply through a bona fide agent?
Yes. The notice indicates that a bona fide agent applying on behalf of a state or local government must provide a letter documenting that status, submitted as part of the application package through Grants.gov.
Is there any special documentation required for bona fide agents?
Yes. A letter documenting bona fide agent status is required and must be submitted as part of the application package via Grants.gov.
When was the opportunity posted?
The posted date is March 1, 2011.
What is the creation date listed for the opportunity?
The creation date is March 17, 2011.
What was the application closing date?
The original/current closing date is April 28, 2011.
When was the opportunity archived?
The archive date is May 28, 2011.
Where should applicants look for complete requirements and instructions?
The announcement states that the "Additional Information" link shown is not active and that applicants should use the "Full Announcement" materials associated with the posting for complete requirements, expectations, and submission instructions.
Who can applicants contact for help accessing the full announcement?
Applicants needing assistance were directed to the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), at 770-488-2700.
How is this opportunity connected to PEPFAR?
The announcement describes the award as a CDC cooperative agreement under PEPFAR, intended to produce surveillance data that can support planning and monitoring of HIV prevention, testing, treatment linkage, and other services within the PEPFAR framework.
Browse more opportunities from the same category: Health
Next opportunity: Strengthening the Capacity of the Dominican Republic to Provide HIV/STI/TB Prevention and Risk Reduction Among Drug Users under the President s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Enhanced Surveillance in the Republic of Uganda under the President s Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1169
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1169) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening the Capacity of the Dominican Republic to Provide HIV/STI/TB Prevention and Risk Reduction Among Drug Users under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1172 Funding Number: CDC RFA GH11 1172 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Demographic Surveillance Study Support in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11101 Funding Number: CDC RFA GH11 11101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Technical Assistance To The Ministry Of Health (MOH) For HIV Services And Program Transition In The Republic Of Mozambique Under The President s Emergency Plan For AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11108 Funding Number: CDC RFA GH11 11108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the Direction Nationale de lEau Potable et de lAssainissement (DINEPA) Apply for CDC RFA GH11 11105 Funding Number: CDC RFA GH11 11105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition Revision for Resuscitation Outcomes Center Randomized Clinical Trial (U01) Apply for RFA HL 11 036 Funding Number: RFA HL 11 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP11 1103 Funding Number: CDC RFA IP11 1103 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 11 004 Funding Number: RFA NS 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| FY 2011 Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 11 004 Funding Number: SM 11 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $360,000 |
| Strengthening the Capacity of Local Indigenous Faith Based Partners in Zambia to Provide HIV/AIDS Prevention, Treatment and Care Services in a Comprehensive and Sustainable Manner under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1120 Funding Number: CDC RFA GH11 1120 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Partnerships for Biodefense (R01) Apply for RFA AI 11 014 Funding Number: RFA AI 11 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Economics of Retirement (R01) Apply for PA 11 138 Funding Number: PA 11 138 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Economics of Retirement (R03) Apply for PA 11 139 Funding Number: PA 11 139 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Economics of Retirement (R21) Apply for PA 11 140 Funding Number: PA 11 140 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Cooperative Agreement with the South Africa National Health Laboratory Service (NHLS) Apply for CDC RFA GH11 1199 Funding Number: CDC RFA GH11 1199 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Part D Coordinated HIV Services and Access to Research for WICY One Time Supplemental Funds Apply for HRSA 11 094 Funding Number: HRSA 11 094 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Program for Early Detection of Certain Medical Conditions Related to Environmental Health Hazards Apply for CDC RFA TS11 1102PPHF11 Funding Number: CDC RFA TS11 1102PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Competitive Revision Applications for NIDCR funded Cooperative Agreements (U01) Apply for PAR 11 144 Funding Number: PAR 11 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Centers for Excellence in Clinical Preventive Services (P01) Apply for RFA HS 11 005 Funding Number: RFA HS 11 005 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| The Infant Immune System Implications for Vaccines and Response to Infections (R01) Apply for RFA AI 11 010 Funding Number: RFA AI 11 010 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| International Research in Infectious Diseases, including AIDS (R01) Apply for PAR 11 145 Funding Number: PAR 11 145 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1169", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.